Literature DB >> 11786103

Lipoprotein particle abnormalities and the impaired lipolysis in renal insufficiency.

Diana M Lee1, Carolyn Knight-Gibson, Ola Samuelsson, Per-Ola Attman, Chi-Sun Wang, Petar Alaupovic.   

Abstract

BACKGROUND: Increased concentrations of very low- (VLDL) and intermediate-density (IDL) lipoproteins in chronic renal failure (CRF) are thought to result from a defect(s) in degradation of plasma triglyceride (TG)-rich lipoproteins. The purpose of this study was to identify lipoprotein abnormalities associated with the reduced lipolytic rate constant, k1, of combined VLDL and IDL substrate from renal patients and asymptomatic controls.
METHODS: The VLDL + IDL were isolated from 18 predialytic patients (CRF-I), 8 patients on hemodialysis (CRF-II) and 10 asymptomatic controls. The lipolytic rate constant (k1) of VLDL + IDL was measured by an assay using bovine milk lipoprotein lipase and determination of TG before and after incubation by gas chromatography (GC). Neutral lipids were measured by GC and apolipoproteins by electroimmunoassays; the apolipoprotein-defined TG-rich lipoproteins including Lp-B:C, Lp-B:C:E and Lp-A-II:B:C:D:E were determined by immunoaffinity chromatography.
RESULTS: The k1 values of VLDL + IDL were significantly (P < 0.001) lower in CRF-I and CRF-II patients (0.0341 and 0.0352 min-1, respectively) than controls (0.0515 min-1). The levels of apolipoproteins B, C-III and E, and TG-rich Lp-B:C, Lp-B:C:E and Lp-A-II:B:C:D:E particles normalized to 100 mg TG per VLDL + IDL were significantly higher in both groups of CRF patients than in controls. All three TG-rich lipoproteins were characterized by significantly increased percent contents of free (FC) and esterified (CE) cholesterol and a decreased percentage of TG. The k1 values of the combined CRF-I and CRF-II patient groups showed significant negative correlations (P < 0.001) with FC (r=-0.81) and CE (r=-0.63) and a positive correlation with TG (r=0.72). Among lipoprotein particles, only Lp-A-II:B:C:D:E levels showed a significant negative correlation with k1 values (r=-0.47, P < 0.03).
CONCLUSIONS: This study shows that the abnormal neutral lipid composition of all three TG-rich lipoprotein particles and increased concentrations of Lp-A-II:B:C:D:E particles represent the main factors affecting the in vitro lipolytic rates of VLDL + IDL substrate in both the CRF patients before dialysis and patients on hemodialysis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11786103     DOI: 10.1046/j.1523-1755.2002.00116.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  11 in total

Review 1.  Dyslipidemia in patients with chronic and end-stage kidney disease.

Authors:  Jad Omran; Ashraf Al-Dadah; Kevin C Dellsperger
Journal:  Cardiorenal Med       Date:  2013-07-13       Impact factor: 2.041

2.  Predictors of incident albuminuria in the Framingham Offspring cohort.

Authors:  Conall M O'Seaghdha; Shih-Jen Hwang; Ashish Upadhyay; James B Meigs; Caroline S Fox
Journal:  Am J Kidney Dis       Date:  2010-11       Impact factor: 8.860

3.  Apolipoprotein-defined lipoproteins and apolipoproteins: associations with abnormal albuminuria in type 1 diabetes in the diabetes control and complications trial/epidemiology of diabetes interventions and complications cohort.

Authors:  Alicia J Jenkins; Jeremy Yu; Petar Alaupovic; Arpita Basu; Richard L Klein; Maria Lopes-Virella; Nathaniel L Baker; Kelly J Hunt; Daniel T Lackland; W Timothy Garvey; Timothy J Lyons
Journal:  J Diabetes Complications       Date:  2013-07-11       Impact factor: 2.852

4.  Relationship between adiposity and cardiovascular risk factors in prevalent hemodialysis patients.

Authors:  George A Kaysen; Peter Kotanko; Fansan Zhu; Shubho R Sarkar; Steven B Heymsfield; Martin K Kuhlmann; Tjien Dwyer; Len Usvyat; Peter Havel; Nathan W Levin
Journal:  J Ren Nutr       Date:  2009-07-10       Impact factor: 3.655

5.  Effects of fish oil during hemodialysis on nutritional status and quality of life: a randomized double-blinded trial.

Authors:  Chi Zhang; Chang Ge; Junsheng Wang; Dong Sun
Journal:  Food Nutr Res       Date:  2020-08-03       Impact factor: 3.894

Review 6.  Lipoprotein metabolism in chronic renal insufficiency.

Authors:  Jeffrey M Saland; Henry N Ginsberg
Journal:  Pediatr Nephrol       Date:  2007-03-28       Impact factor: 3.714

7.  Chronic kidney disease delays VLDL-apoB-100 particle catabolism: potential role of apolipoprotein C-III.

Authors:  Doris T Chan; Gursharan K Dogra; Ashley B Irish; Esther M Ooi; P Hugh Barrett; Dick C Chan; Gerald F Watts
Journal:  J Lipid Res       Date:  2009-06-21       Impact factor: 5.922

Review 8.  Mitochondrial Activity and Skeletal Muscle Insulin Resistance in Kidney Disease.

Authors:  Jane E Carré; Charles Affourtit
Journal:  Int J Mol Sci       Date:  2019-06-05       Impact factor: 5.923

9.  Serum lipid profile constituents as markers of cardiovascular morbidity in patients on chronic hemodialysis.

Authors:  Dimitrios Kirmizis; Evangelia Koutoupa; Apostolos Tsiandoulas; Aphroditi Valtopoulou; Georgios Niavis; Phani Markou; Konstantinos Barboutis
Journal:  Biomark Insights       Date:  2007-02-07

10.  Risk factors for subclinical renal damage and its progression: Hanzhong Adolescent Hypertension Study.

Authors:  Yang Wang; Ming-Fei Du; Wei-Hua Gao; Bo-Wen Fu; Qiong Ma; Yu Yan; Yue Yuan; Chao Chu; Chen Chen; Yue-Yuan Liao; Ke Gao; Ke-Ke Wang; Min Li; Yue Sun; Jia-Wen Hu; Xin Chen; Qiong Ma; Dan Wang; Xiao-Yu Zhang; Chun-Hua Li; Hao-Wei Zhou; Wan-Hong Lu; Zu-Yi Yuan; John Chang; Jian-Jun Mu
Journal:  Eur J Clin Nutr       Date:  2020-09-29       Impact factor: 4.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.